CD4 and glioblastoma: Mu et al. demonstrated that CD4+ was the predominant T cell population in primary GBM, highly expressed also in bevacizumab-resistant recurrent tumors, and together with perivascular Foxp3+ T cells correlated with angiogenesis in glioma [38].